Search
for
Sort by
Research 601–630 of 1000+
- The Pharmacokinetics of 2.5- to 10-mg Oral Doses of Minoxidil in Healthy Volunteers
- Low-dose (2.5 mg/day) finasteride treatment in hirsutism
- Design, synthesis and biological evaluation of novel androst-3,5-diene-3-carboxylic acid derivatives as inhibitors of 5α-reductase type 1 and 2
- Homology Modeling of 5-alpha-Reductase 2 Using Available Experimental Data
- Efficacy of 2.5 mg oral biotin versus 5% topical minoxidil in increasing nail growth rate
- Skin Tissue: A Place for SARS-CoV-2 to Multiply and Transmit?
- Secreted Frizzled‐Related Protein 2 ( SFRP2 ) Induces Follistatin‐Like 1 ( FSTL1 ) to Regulate Dihydrotestosterone ( DHT )‐Induced Dermal Papilla Cell Mitochondrial Dysfunction and Senescence
- Tannic acid-modified MoS 2 /silk fibroin hydrogel photothermal antibacterial synergistic macrophage M2 polarization regulation for the treatment of diabetic ulcers
- Efficacy of 2.5mg oral biotin versus 5% topical minoxidil in increasing nail growth rate.
- Whole-genome SNP genotyping mapped a novel locus for hereditary hypotrichosis on chromosome 2q31.1–q32.2
- Sponsored Lecture 2 : Global aspects of acne treatment: current & future benefits
- Enhanced Iontophoretic Delivery of Magnesium Ascorbyl 2-Phosphate and Sodium Fluorescein to Hairless and Hairy Mouse Skin
- 1424 METHYLATION AND DECREASED EXPRESSION OF 5-ALPHA REDUCTASE 2 IN HUMAN PROSATE SAMPLES: IMPLICATIONS FOR RESISTANCE TO THERAPY FOR BPH
- Methylated CpG dinucleotides in 5-α reductase 2 gene might explain the finasteride-resistance in BPE patients
- P163 : Clinical efficacy of 2.5mg/day finasteride in female pattern hair loss
- Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment
- Systemic Steroids With or Without 2% Topical Minoxidil in the Treatment of Alopecia Areata
- Diseases associated with hidranitis suppurativa: part 2 of a series on hidradenitis
- The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression Levels in Patients with Comorbidities on COVID-19 Severity: A Comprehensive Review
- Effects of a novel finasteride 0.25% topical solution on scalp and serum dihydrotestosterone in healthy men with androgenetic alopecia
- Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study
- Epidermal mammalian target of rapamycin complex 2 controls lipid synthesis and filaggrin processing in epidermal barrier formation
- Evaluating cepharanthine analogues as natural drugs against SARS‐CoV‐2
- Prostaglandin E <sub>2</sub> Receptor 2 Modulates Macrophage Activity for Cardiac Repair
- METHOTREXATE FOR GENERALIZED PUSTULAR PSORIASIS IN A 2-YEAR-OLD CHILD
- Analysis of genetic polymorphisms of steroid 5α-reductase type 1 and 2 genes in Korean men with androgenetic alopecia
- Clinical efficacy of oral administration of finasteride at a dose of 2.5 mg/day in women with female pattern hair loss
- Synthesis, Crystal Structure and Supramolecular Features of Novel 2,4-Diaminopyrimidine Salts
- Effect of palbociclib plus letrozole on patient-reported health-related quality of life: extended follow-up of the PALOMA-2 trial
- Safety and quality of life of CDK4/6 inhibitors therapy for hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: a multicenter cross-sectional survey in China